bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
0.499
-0.014 (-2.65%)
At close: Oct 24, 2024, 4:00 PM
0.500
+0.001 (0.18%)
After-hours: Oct 24, 2024, 5:08 PM EDT
bluebird bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 54.59 | 29.07 | 2.74 | 2.85 | - | - | Upgrade
|
| Other Revenue | 0.31 | 0.43 | 0.86 | 0.81 | - | - | Upgrade
|
| Revenue | 54.9 | 29.5 | 3.6 | 3.66 | - | - | Upgrade
|
| Revenue Growth (YoY) | 483.79% | 720.04% | -1.77% | - | - | - | Upgrade
|
| Cost of Revenue | 76.13 | 33.53 | 10.08 | 354.8 | 319.31 | 327.12 | Upgrade
|
| Gross Profit | -21.23 | -4.03 | -6.48 | -351.14 | -319.31 | -327.12 | Upgrade
|
| Selling, General & Admin | 206.82 | 190.38 | 169.47 | 209.97 | 239.95 | 235.84 | Upgrade
|
| Research & Development | 122.33 | 142.79 | 171.3 | - | - | - | Upgrade
|
| Other Operating Expenses | - | -92.93 | -102 | - | - | - | Upgrade
|
| Operating Expenses | 329.15 | 240.23 | 238.77 | 209.97 | 239.95 | 235.84 | Upgrade
|
| Operating Income | -350.38 | -244.26 | -245.25 | -561.11 | -559.26 | -562.96 | Upgrade
|
| Interest Expense | -18.64 | -16.35 | -6.32 | - | - | - | Upgrade
|
| Interest & Investment Income | 9.78 | 9.87 | 1.03 | 0.88 | 5.77 | 17.38 | Upgrade
|
| Other Non Operating Income (Expenses) | 39.96 | 38.71 | 28.39 | -1.7 | 0.34 | -0.69 | Upgrade
|
| EBT Excluding Unusual Items | -319.28 | -212.04 | -222.15 | -561.93 | -553.15 | -546.27 | Upgrade
|
| Merger & Restructuring Charges | - | - | -4.94 | -29.81 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -3.14 | 29.36 | -7.22 | -9.3 | Upgrade
|
| Pretax Income | -319.28 | -212.04 | -230.23 | -562.38 | -560.37 | -555.57 | Upgrade
|
| Income Tax Expense | -0.03 | -0.13 | 0.12 | 0.26 | 0.69 | -0.55 | Upgrade
|
| Earnings From Continuing Operations | -319.25 | -211.91 | -230.34 | -562.64 | -561.06 | -555.02 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -256.74 | -57.64 | -234.59 | Upgrade
|
| Net Income | -319.25 | -211.91 | -230.34 | -819.38 | -618.7 | -789.61 | Upgrade
|
| Net Income to Common | -319.25 | -211.91 | -230.34 | -819.38 | -618.7 | -789.61 | Upgrade
|
| Shares Outstanding (Basic) | 154 | 110 | 79 | 69 | 62 | 55 | Upgrade
|
| Shares Outstanding (Diluted) | 154 | 110 | 79 | 69 | 62 | 55 | Upgrade
|
| Shares Change (YoY) | 62.35% | 39.75% | 14.04% | 10.83% | 12.66% | 6.07% | Upgrade
|
| EPS (Basic) | -2.08 | -1.93 | -2.93 | -11.89 | -9.95 | -14.31 | Upgrade
|
| EPS (Diluted) | -2.08 | -1.93 | -2.93 | -11.89 | -9.95 | -14.31 | Upgrade
|
| Free Cash Flow | -250.2 | -239.24 | -324.43 | -650.14 | -499.34 | -635.41 | Upgrade
|
| Free Cash Flow Per Share | -1.63 | -2.18 | -4.13 | -9.43 | -8.03 | -11.51 | Upgrade
|
| Gross Margin | -38.67% | -13.66% | -180.15% | - | - | - | Upgrade
|
| Operating Margin | -638.21% | -828.09% | -6818.04% | -15322.36% | - | - | Upgrade
|
| Profit Margin | -581.51% | -718.42% | -6403.73% | -22375.15% | - | - | Upgrade
|
| Free Cash Flow Margin | -455.74% | -811.05% | -9019.38% | -17753.74% | - | - | Upgrade
|
| EBITDA | -302.11 | -215.74 | -236.9 | -555.65 | -553.63 | -558.52 | Upgrade
|
| D&A For EBITDA | 48.27 | 28.53 | 8.34 | 5.45 | 5.63 | 4.44 | Upgrade
|
| EBIT | -350.38 | -244.26 | -245.25 | -561.11 | -559.26 | -562.96 | Upgrade
|
| Revenue as Reported | 54.9 | 29.5 | 3.6 | 3.66 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.